Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
2003 1
2004 7
2005 6
2006 4
2007 5
2008 3
2009 4
2010 4
2011 8
2012 15
2013 12
2014 7
2015 4
2016 6
2017 3
2018 5
2019 6
2020 7
2021 7
2022 6
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.
Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A, Nordbeck P, Olivotto I, Pietilä-Effati P, Namdar M. Pieroni M, et al. Among authors: namdar m. J Am Coll Cardiol. 2021 Feb 23;77(7):922-936. doi: 10.1016/j.jacc.2020.12.024. J Am Coll Cardiol. 2021. PMID: 33602475 Free article. Review.
European expert consensus statement on therapeutic goals in Fabry disease.
Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ. Wanner C, et al. Among authors: namdar m. Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Mol Genet Metab. 2018. PMID: 30017653 Review.
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.
Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, Linhart A, Mignani R, Namdar M, Nowak A, Oliveira JP, Pieroni M, Viana-Baptista M, Wanner C, Spada M. Germain DP, et al. Among authors: namdar m. Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun. Mol Genet Metab Rep. 2019. PMID: 30775256 Free PMC article. Review.
Emerging biomarkers for cardiac arrhythmias.
Hammerer-Lercher A, Namdar M, Vuilleumier N. Hammerer-Lercher A, et al. Among authors: namdar m. Clin Biochem. 2020 Jan;75:1-6. doi: 10.1016/j.clinbiochem.2019.11.012. Epub 2019 Nov 28. Clin Biochem. 2020. PMID: 31786205 Review.
Atrial fibrillation outcomes: changing the paradigm.
Casado-Arroyo R, Chierchia GB, Rodriguez-Mañero M, Levinstein M, Namdar M, Conte G, Sieira J, Sarkozy A, de Asmundis C, Wauters K, Brugada P. Casado-Arroyo R, et al. Among authors: namdar m. Int J Cardiol. 2013 Jun 20;166(2):545-7. doi: 10.1016/j.ijcard.2012.09.185. Epub 2012 Dec 21. Int J Cardiol. 2013. PMID: 23266298 Review. No abstract available.
106 results